Filing Flows › Beta Bionics (BBNX) › Guidance history
Beta Bionics (BBNX) guidance history: what it guided and what it reported
Beta Bionics gave guidance in 3 earnings releases on file since Jan 8, 2026.
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 59.0% (Feb 17, 2026) | — | to be reported | — |
The latest quarter
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
Questions
Does Beta Bionics beat its guidance?
Beta Bionics gave guidance in 3 earnings releases on file since Jan 8, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.